Financials
- Market Capitalization 355.58 M
- Employee 35
- Founded 1996
- CEO N/A
- Website www.fennecpharma.com
- Headquarter British Columbia, Canada
- FIGI BBG000DTH814
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-22.65
売上高対価格比率
4.93
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3066 | KYTX Kyverna Therapeutics, Inc. - Common Stock | 5.92 USD | -4.67% | -6.48% | -18.34% | -11.38% | 366.11 M USD | ||
| 3068 | RLMD Relmada Therapeutics, Inc. - Common Stock | 3.43 USD | -2.28% | +1.18% | -24.28% | +73.23% | 365.88 M USD | ||
| 3097 | CCCC C4 Therapeutics, Inc. - Common Stock | 2.87 USD | -6.21% | -1.37% | -17.05% | +36.67% | 353.08 M USD | ||
| 3118 | OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.74 USD | -2.88% | -2.21% | -6.06% | +79.38% | 345.00 M USD |